MENLO PARK, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB ) will hold its quarterly conference call to discuss its Second Quarter 2018 Financial Results on Thursday, August 2, 2018, at 4:30pm Eastern Time.

The call will be webcast and may be accessed at Pacific Biosciences’ website at:  http://investor.pacificbiosciences.com/ .

Date:  August 2, 2018

Time:  4:30pm ET

Listen via Internet:  http://investor.pacificbiosciences.com/

Toll-free:  888.366.7247

International:  707.287.9330

Conference ID: 2075988

Replay:  http://investor.pacificbiosciences.com

About Pacific Biosciences Pacific Biosciences of California, Inc. (NASDAQ: PACB ) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT ® ) technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and the ability to simultaneously detect epigenetic changes. PacBio ® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com .

Pacific Biosciences Trevin Rard 650.521.8450 ir@pacificbiosciences.com